Sinovac Biotech Ltd (NASDAQ:SVA)
| 0.00 Delayed Data As of Dec 30 |  0.00 / 0.00%Today’s Change | -- |||52-Week Range -- | -- Year-to-Date |
Five Year Financial Summary
| All Currency in US Dollars | 4 Quarter Trend | |||||
|---|---|---|---|---|---|---|
| Quarter 2 2016 | Quarter 3 2016 | Quarter 4 2016 | Quarter 1 2019 | |||
| Assets | Cash | 50.8M | 54.6M | 65.4M | 149.0M | |
| Short Term Investment Cash | -13.3M | 5.2M | 9.5M | -9.1M | ||
| Cash & Short Term Investments | 50.8M | 54.6M | 65.4M | 168.4M | ||
| Receivables | Receivables | 29.6M | 47.5M | 49.8M | 82.0M | |
| Inventories | Inventories | 21.5M | 19.6M | 14.1M | 29.8M | |
| Current Assets | Other Current Assets | 4.8M | 4.2M | 4.9M | 3.1M | |
| Current Assets | 106.8M | 125.9M | 134.2M | 283.2M | ||
| Total Assets | Property, Plant and Equipment - Gross | -- | -- | 106.2M | -- | |
| Depreciation | -- | -- | -38.4M | -- | ||
| Other Assets | 9.3M | 9.2M | 8.8M | 8.6M | ||
| Total Assets | 181.4M | 203.7M | 211.4M | 381.9M | ||
| Liabilities | Accounts Payable | 22.1M | 26.0M | 1.8M | 46.6M | |
| Short Term Debt | 26.2M | 31.8M | 33.6M | 5.3M | ||
| Accrued Expenses | -- | -- | 8.6M | -- | ||
| Other Current Liabilities | 2.0M | 7.3M | 22.3M | 4.0M | ||
| Other Liabilities | 50.6M | 66.0M | 66.3M | 56.6M | ||
| Total Liabilities | Long Term Debt | 3.0M | 6.0M | 9.4M | 15.7M | |
| Deferred Taxes | -539.0K | -428.0K | -452.0K | -6.6M | ||
| Other Liabilities | 737.0K | 734.0K | 2.9M | 3.1M | ||
| Total Liabilities | 54.4M | 72.8M | 78.7M | 75.4M | ||
| Equity | Minority Interest | -3.0M | -1.1M | -2.4M | -1.8M | |
| Preferred Stock | 0.00 | 0.00 | 0.00 | 15.0K | ||
| Common Equity | 111.8M | 115.0M | 115.8M | 259.1M | ||
| Total Shareholder Equity | 111.8M | 115.0M | 115.8M | 259.1M | ||
| Share Information | Common Shares Outstanding | 56.9M | 56.9M | 57.0M | 99.0M | |
| Addtl. Info. | No data currently available for this section. | |||||
